Radioligands in the future of prostate cancer treatment

Radioligands in the future of prostate cancer treatment

PSMAfore: Radioligand Therapy in the Future of Prostate Cancer TreatmentПодробнее

PSMAfore: Radioligand Therapy in the Future of Prostate Cancer Treatment

Future Directions in mCRPC: Novel Therapies and the Role of Radium, Radioligand TreatmentsПодробнее

Future Directions in mCRPC: Novel Therapies and the Role of Radium, Radioligand Treatments

Breakthroughs in Prostate Cancer TreatmentПодробнее

Breakthroughs in Prostate Cancer Treatment

Mastering the Art of Radioligand therapyПодробнее

Mastering the Art of Radioligand therapy

Uromigos Live 2023: Current and Future Status of Radioligand Therapy in Prostate CancerПодробнее

Uromigos Live 2023: Current and Future Status of Radioligand Therapy in Prostate Cancer

Looking Ahead: What Does the Future Hold for Radioligand Therapy in Prostate Cancer?Подробнее

Looking Ahead: What Does the Future Hold for Radioligand Therapy in Prostate Cancer?

Future approaches in CRPC: radioligands, CAR-T and bispecificsПодробнее

Future approaches in CRPC: radioligands, CAR-T and bispecifics

Diagnosing Prostate Cancer: Moving Beyond PSAs, Gleason Scores and Biopsies Through Advanced ImagingПодробнее

Diagnosing Prostate Cancer: Moving Beyond PSAs, Gleason Scores and Biopsies Through Advanced Imaging

Integrating Theranostics into a Group PracticeПодробнее

Integrating Theranostics into a Group Practice

1st Radioligand therapy (RLT) approved in EuropeПодробнее

1st Radioligand therapy (RLT) approved in Europe

PSMA Targeting for Treatment of Advanced Prostate Cancer - 2021 Prostate Cancer Patient ConferenceПодробнее

PSMA Targeting for Treatment of Advanced Prostate Cancer - 2021 Prostate Cancer Patient Conference

Radiotherapy and AI in the future of prostate cancer treatmentПодробнее

Radiotherapy and AI in the future of prostate cancer treatment

Популярное